Perspectives on Sotatercept in Pulmonary Arterial Hypertension
Journal of Clinical Medicine · 28.10.2024 · 13 (21) · 6463
DOI: 10.3390/jcm13216463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.10.2024. Verfasst von Rosalinda Madonna und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, 56124 Pisa, Italy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca Scientifica, Ministero dell'Universita e della Ricerca Scientifica, European Union—Next-Generation EU through the Italian Ministry of University and Research under PNRR—M4C2-I1.3 Project PE_00000019 “HEAL ITALIA”.
Abstract (Originalsprache)
Sotatercept acts as a type IIA-Fc activin receptor, thereby scavenging free activin from its physiological membrane receptor. Through this type of action, sotaterpect leads to a rebalancing of the proliferation and antiproliferation pathways of pulmonary smooth muscle cells in response to bone morphogenic protein (BMP). Although sotatercept has been approved as the fourth pillar of therapy for group 1 pulmonary arterial hypertension (PAH) in the United States and Europe, several studies are ongoing to broaden the application of the drug to non-Group 1 PAH. We provide an overview of the clinical and preclinical evidence of targeting the activation pathway by sotatercept in the treatment of PAH. We also discuss other potential applications of sotatercept in the context of pulmonary hypertension other than PAH group 1.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Division, Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, 56124 Pisa, Italy.
- Cardiology Division, Pisa University Hospital, Via Paradisa, 2, 56124 Pisa, Italy.
Förderung
- Ministero dell'Università e della Ricerca Scientifica
- Ministero dell'Universita e della Ricerca Scientifica
- European Union—Next-Generation EU through the Italian Ministry of University and Research under PNRR—M4C2-I1.3 Project PE_00000019 “HEAL ITALIA”
Zitieren
APA
Madonna, R., & Biondi, F. (2024). Perspectives on Sotatercept in Pulmonary Arterial Hypertension. Journal of Clinical Medicine, 13(21), 6463. https://doi.org/10.3390/jcm13216463
Vancouver
Madonna R, Biondi F. Perspectives on Sotatercept in Pulmonary Arterial Hypertension. Journal of Clinical Medicine. 2024;13(21):6463. doi:10.3390/jcm13216463
BibTeX
@article{Madonna2024,
author = {Madonna, Rosalinda and Biondi, Filippo},
title = {Perspectives on Sotatercept in Pulmonary Arterial Hypertension},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {21},
pages = {6463},
doi = {10.3390/jcm13216463}
}
EUVIMED